CD1 antigen presentation: How it works

Nature Reviews Immunology

Volumn 7, Issue 12, 2007, Pages 929-941

  Barral, Duarte C ^a   Brenner, Michael B ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; CD1 ANTIGEN; GANGLIOSIDE GD3; LIPID; LIPOARABINOMANNAN; LIPOPHOSPHOGLYCAN; MANNOSIDE; MYCOLIC ACID; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLINOSITOL; SPHINGOLIPID ACTIVATOR PROTEIN;

ADAPTIVE IMMUNITY; ANTIGEN BINDING; ANTIGEN PRESENTATION; CELL DIFFERENTIATION; CELL FUNCTION; CELL MATURATION; CELL MEMBRANE; CELL POPULATION; CRYSTAL STRUCTURE; DENDRITIC CELL; ENDOPLASMIC RETICULUM; HUMAN; INNATE IMMUNITY; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN STRUCTURE; REVIEW; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, CD1; CARRIER PROTEINS; CELL MEMBRANE; CRYSTALLIZATION; DENDRITIC CELLS; ENDOCYTOSIS; ENDOPLASMIC RETICULUM; HUMANS; KILLER CELLS, NATURAL; LIPID METABOLISM; LIPIDS; LYMPHOCYTE ACTIVATION; PROTEIN TRANSPORT; SAPONINS;

EID: 36448952375     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/nri2191     Document Type: Review

References (134)

1. Tupin, E., Kinjo, Y. & Kronenberg, M. The unique role of natural killer T cells in the response to microorganisms. Nature Rev. Microbiol. 5, 405-417 (2007).
2. Bendelac, A., Savage, P. B. & Teyton, L. The biology of NKT cells. Annu. Rev. Immunol. 25, 297-336 (2007).
3. + T cells. Nature 372, 691-694 (1994). This is the first report showing that CD1 presents a lipid antigen - a mycolic acid from M. tuberculosis.
4. Brennan, P. J. & Nikaido, H. The envelope of mycobacteria. Annu. Rev. Biochem. 64, 29-63 (1995).
5. Sieling, P. A. et al. CD1-restricted T cell recognition of microbial lipoglycan antigens. Science 269, 227-230 (1995).
6. Moody, D. B. et al. CD1c-mediated T-cell recognition of isoprenoid glycolipids in Mycobacterium tuberculosis infection. Nature 404, 884-888 (2000).
7. Ulrichs, T., Moody, D. B., Grant, E., Kaufmann, S. H. & Porcelli, S. A. T-cell responses to CD1-presented lipid antigens in humans with Mycobacterium tuberculosis infection. Infect. Immun. 71, 3076-3087 (2003).
8. Gilleron, M. et al. Diacylated sulfoglycolipids are novel mycobacterial antigens stimulating CD1-restricted T cells during infection with Mycobacterium tuberculosis. J. Exp. Med. 199, 649-659 (2004).
9. Kinjo, Y. et al. Recognition of bacterial glycosphingolipids by natural killer T cells. Nature 434, 520-525 (2005).
10. Mattner, J. et al. Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 434, 525-529 (2005).
11. Kinjo, Y. et al. Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria. Nature Immunol. 7, 978-986 (2006). This study found that iNKT cells can recognize glycolipids from pathogenic bacteria, namely from B. burgdorferi.
12. Amprey, J. L. et al. A subset of liver NK T cells is activated during Leishmania donovani infection by CD1d-bound lipophosphoglycan. J. Exp. Med. 200, 895-904 (2004).
13. - cytolytic T lymphocytes. Nature 341, 447-450 (1989).
14. + T lymphocytes. Science 268, 863-865 (1995).
15. + T cells in major histocompatibility complex class II-deficient mice. J. Exp. Med. 182, 993-1004 (1995).
16. Kronenberg, M. Toward an understanding of NKT cell biology: progress and paradoxes. Annu. Rev. Immunol. 23, 877-900 (2005).
17. Vincent, M. S., Xiong, X., Grant, E. P., Peng, W. & Brenner, M. B. CD1a-, b-, and c-restricted TCRs recognize both self and foreign antigens. J. Immunol. 175, 6344-6351 (2005).
18. Gumperz, J. E. et al. Murine CD1d-restricted T cell recognition of cellular lipids. Immunity 12, 211-221 (2000).
19. Shamshiev, A. et al. Presentation of the same glycolipid by different CD1 molecules. J. Exp. Med. 195, 1013-1021 (2002).
20. Shamshiev, A. et al. The αβ T cell response to self-glycolipids shows a novel mechanism of CD1b loading and a requirement for complex oligosaccharides. Immunity 13, 255-264 (2000).
21. Shamshiev, A. et al. Self glycolipids as T-cell autoantigens. Eur. J. Immunol. 29, 1667-1675 (1999).
22. Wu, D. Y., Segal, N. H., Sidobre, S., Kronenberg, M. & Chapman, P. B. Cross-presentation of disialoganglioside GD3 to natural killer T cells. J. Exp. Med. 198, 173-181 (2003).
23. Zhou, D. et al. Lysosomal glycosphingolipid recognition by NKT cells. Science 306, 1786-1789 (2004).
24. Speak, A. O. et al. Implications for invariant natural killer T cell ligands due to the restricted presence of isoglobotrihexosylceramide in mammals. Proc. Natl Acad. Sci. USA 104, 5971-5976 (2007).
25. Porubsky, S. et al. Normal development and function of invariant natural killer T cells in mice with isoglobotrihexosylceramide (iGb3) deficiency. Proc. Natl Acad. Sci. USA 104, 5977-5982 (2007).
26. Zeng, Z. et al. Crystal structure of mouse CD1: an MHC-like fold with a large hydrophobic binding groove. Science 277, 339-345 (1997). The first CD1 crystal structure (mouse CD1d) shows the basic architecture of the antigen-binding groove and how lipids can be accommodated in it.
27. Zajonc, D. M., Elsliger, M. A., Teyton, L. & Wilson, I. A. Crystal structure of CD1a in complex with a sulfatide self antigen at a resolution of 2.15 Å. Nature Immunol. 4, 808-815 (2003).
28. Zajonc, D. M. et al. Molecular mechanism of lipopeptide presentation by CD1a. Immunity 22, 209-219 (2005).
29. Gadola, S. D. et al. Structure of human CD1b with bound ligands at 2.3 Å, a maze for alkyl chains. Nature Immunol. 3, 721-726 (2002). The crystal structure of CD1b revealed how very long alkyl chains can be accommodated in the antigen-binding compartment.
30. Borg, N. A. et al. CD1d-lipid-antigen recognition by the semi-invariant NKT T-cell receptor. Nature 448, 44-49 (2007).
31. Sugita, M., Porcelli, S. A. & Brenner, M. B. Assembly and retention of CD1b heavy chains in the endoplasmic reticulum. J. Immunol. 159, 2358-2365 (1997).
32. 2-microglobulin. Int. Immunol. 11, 1615-1623 (1999).
33. Kang, S. J. & Cresswell, P. Calnexin, calreticulin, and ERp57 cooperate in disulfide bond formation in human CD1d heavy chain. J. Biol. Chem. 277, 44838-44844 (2002).
34. Hughes, E. A. & Cresswell, P. The thiol oxidoreductase ERp57 is a component of the MHC class I peptide-loading complex. Curr. Biol. 8, 709-712 (1998).
35. Morrice, N. A. & Powis, S. J. A role for the thiol-dependent reductase ERp57 in the assembly of MHC class I molecules. Curr. Biol. 8, 713-716 (1998).
36. 2-microglobulin for expression and formation of human CD1 antigens. Eur. J. Immunol. 27, 1366-1373 (1997).
37. 2-microglobulin-dependent surface expression of functional mouse CD1.1. J. Exp. Med. 182, 1913-1919 (1995).
38. 2-microglobulin-independent MHC class Ib molecule expressed by human intestinal epithelium. Science 265, 259-262 (1994).
39. 2-microglobulin. J. Biol. Chem. 274, 9289-9295 (1999).
40. Brossay, L. et al. Mouse CD1 is mainly expressed on hemopoietic-derived cells. J. Immunol. 159, 1216-1224 (1997).
41. 2-microglobulin-dependent and independent forms. J. Immunol. 161, 1710-1717 (1998).
42. Joyce, S. et al. Natural ligand of mouse CD1d1: cellular glycosylphosphatidylinositol. Science 279, 1541-1544 (1998).
43. De Silva, A. D. et al. Lipid protein interactions: the assembly of CD1d1 with cellular phospholipids occurs in the endoplasmic reticulum. J. Immunol. 168, 723-733 (2002).
44. Park, J. J. et al. Lipid-protein interactions: biosynthetic assembly of CD1 with lipids in the endoplasmic reticulum is evolutionarily conserved. Proc. Natl Acad. Sci. USA 101, 1022-1026 (2004).
45. Garcia-Alles, L. F. et al. Endogenous phosphatidylcholine and a long spacer ligand stabilize the lipid-binding groove of CD1b. EMBO J. 25, 3684-3692 (2006). References 42-45 found that endogenous lipids are loaded onto CD1 molecules, which might stabilize the molecules during assembly and trafficking.
46. Gadola, S. D. et al. Impaired selection of invariant natural killer T cells in diverse mouse models of glycosphingolipid lysosomal storage diseases. J. Exp. Med. 203, 2293-2303 (2006).
47. Batuwangala, T. et al. The crystal structure of human CD1b with a bound bacterial glycolipid. J. Immunol. 172, 2382-2388 (2004).
48. Sharp, D. et al. Cloning and gene defects in microsomal triglyceride transfer protein associated with abetalipoproteinaemia. Nature 365, 65-69 (1993).
49. Wetterau, J. R. et al. Absence of microsomal triglyceride transfer protein in individuals with abetalipoproteinemia. Science 258, 999-1001 (1992).
50. Brozovic, S. et al. CD1d function is regulated by microsomal triglyceride transfer protein. Nature Med. 10, 535-539 (2004).
51. Dougan, S. K. et al. Microsomal triglyceride transfer protein lipidation and control of CD1d on antigen-presenting cells. J. Exp. Med. 202, 529-539 (2005).
52. Sagiv, Y. et al. A distal effect of microsomal triglyceride transfer protein deficiency on the lysosomal recycling of CD1d. J. Exp. Med. 204, 921-928 (2007).
53. Briken, V., Jackman, R. M., Dasgupta, S., Hoening, S. & Porcelli, S. A. Intracellular trafficking pathway of newly synthesized CD1b molecules. EMBO J. 21, 825-834 (2002).
54. Jayawardena-Wolf, J., Benlagha, K., Chiu, Y. H., Mehr, R. & Bendelac, A. CD1d endosomal trafficking is independently regulated by an intrinsic CD1d-encoded tyrosine motif and by the invariant chain. Immunity 15, 897-908 (2001).
55. Kang, S. J. & Cresswell, P. Regulation of intracellular trafficking of human CD1d by association with MHC class II molecules. EMBO J. 21, 1650-1660 (2002).
56. Bonifacino, J. S. & Traub, L. M. Signals for sorting of transmembrane proteins to endosomes and lysosomes. Annu. Rev. Biochem. 72, 395-447 (2003).
57. Sugita, M. et al. Cytoplasmic tail-dependent localization of CD1b antigen-presenting molecules to MIICs. Science 273, 349-352 (1996).
58. Sugita, M., van Der Wel, N., Rogers, R. A., Peters, P. J. & Brenner, M. B. CD1c molecules broadly survey the endocytic system. Proc. Natl Acad. Sci. USA 97, 8445-8450 (2000).
59. Lawton, A. P. et al. The mouse CD1d cytoplasmic tail mediates CD1d trafficking and antigen presentation by adaptor protein 3-dependent and -independent mechanisms. J. Immunol. 174, 3179-3186 (2005).
60. Chiu, Y. H. et al. Distinct subsets of CD1d-restricted T cells recognize self-antigens loaded in different cellular compartments. J. Exp. Med. 189, 103-110 (1999).
61. Chiu, Y. H. et al. Multiple defects in antigen presentation and T cell development by mice expressing cytoplasmic tail-truncated CD1d. Nature Immunol. 3, 55-60 (2002). References 60 and 61 show the importance of the intracellular trafficking of CD1d, which is controlled by its cytoplasmic tail, for the function of the molecule.
62. Sugita, M. et al. Separate pathways for antigen presentation by CD1 molecules. Immunity 11, 743-752 (1999). This paper describes the differential trafficking of CD1a and CD1b and how, collectively, these CD1 isoforms can broadly survey the endocytic system.
63. Salamero, J. et al. CD1a molecules traffic through the early recycling endosomal pathway in human Langerhans cells. J. Invest. Dermatol. 116, 401-408 (2001).
64. Sugita, M. et al. Failure of trafficking and antigen presentation by CD1 in AP-3-deficient cells. Immunity 16, 697-706 (2002).
65. Cernadas, M. et al. Lysosomal localization of murine CD1d mediated by AP-3 is necessary for NK T cell development. J. Immunol. 171, 4149-4155 (2003).
66. Elewaut, D. et al. The adaptor protein AP-3 is required for CD1d-mediated antigen presentation of glycosphingolipids and development of Vα14 iNKT cells. J. Exp. Med. 198, 1133-1146 (2003).
67. Jackman, R. M. et al. The tyrosine-containing cytoplasmic tail of CD1b is essential for its efficient presentation of bacterial lipid antigens. Immunity 8, 341-351 (1998).
68. Boes, M. et al. T-cell engagement of dendritic cells rapidly rearranges MHC class II transport. Nature 418, 983-988 (2002).
69. Chow, A., Toomre, D., Garrett, W. & Mellman, I. Dendritic cell maturation triggers retrograde MHC class II transport from lysosomes to the plasma membrane. Nature 418, 988-994 (2002).
70. Yuan, W., Dasgupta, A. & Cresswell, P. Herpes simplex virus evades natural killer T cell recognition by suppressing CD1d recycling. Nature Immunol. 7, 835-842 (2006).
71. Pierre, P. et al. Developmental regulation of MHC class II transport in mouse dendritic cells. Nature 388, 787-792 (1997).
72. Sallusto, F., Cella, M., Danieli, C. & Lanzavecchia, A. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J. Exp. Med. 182, 389-400 (1995).
73. Cella, M., Engering, A., Pinet, V., Pieters, J. & Lanzavecchia, A. Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells. Nature 388, 782-787 (1997).
74. Cao, X. et al. CD1 molecules efficiently present antigen in immature dendritic cells and traffic independently of MHC class II during dendritic cell maturation. J. Immunol. 169, 4770-4777 (2002).
75. van der Wel, N. N. et al. CD1 and major histocompatibility complex II molecules follow a different course during dendritic cell maturation. Mol. Biol. Cell 14, 3378-3388 (2003).
76. Mahley, R. W., Weisgraber, K. H. & Farese, R. V. J. in Williams Textbook of Endocrinology (eds Larsen, P. R., Kronenberg, H. M., Melmed, S. & Polonsky, K. S.) 1642-1663 (Saunders, Philadelphia, 2003).
77. Jeon, H. & Blacklow, S. C. Structure and physiologic function of the low-density lipoprotein receptor. Annu. Rev. Biochem. 74, 535-562 (2005).
78. Heeren, J., Weber, W. & Beisiegel, U. Intracellular processing of endocytosed triglyceride-rich lipoproteins comprises both recycling and degradation. J. Cell Sci. 112, 349-359 (1999).
79. van den Elzen, P. et al. Apolipoprotein-mediated pathways of lipid antigen presentation. Nature 437, 906-910 (2005).
80. Greaves, D. R. & Gordon, S. Thematic review series: the immune system and atherogenesis. Recent insights into the biology of macrophage scavenger receptors. J. Lipid Res. 46, 11-20 (2005).
81. Figdor, C. G., van Kooyk, Y. & Adema, G. J. C-type lectin receptors on dendritic cells and Langerhans cells. Nature Rev. Immunol. 2, 77-84 (2002).
82. Prigozy, T. I. et al. The mannose receptor delivers lipoglycan antigens to endosomes for presentation to T cells by CD1b molecules. Immunity 6, 187-197 (1997).
83. Mc Dermott, R. et al. Birbeck granules are subdomains of endosomal recycling compartment in human epidermal Langerhans cells, which form where Langerin accumulates. Mol. Biol. Cell 13, 317-335 (2002).
84. Hunger, R. E. et al. Langerhans cells utilize CD1a and langerin to efficiently present nonpeptide antigens to T cells. J. Clin. Invest. 113, 701-708 (2004).
85. Di Paolo, G. & De Camilli, P. Phosphoinositides in cell regulation and membrane dynamics. Nature 443, 651-657 (2006).
86. Kobayashi, T., Gu, F. & Gruenberg, J. Lipids, lipid domains and lipid-protein interactions in endocytic membrane traffic. Semin. Cell Dev. Biol. 9, 517-526 (1998).
87. Mukherjee, S., Soe, T. T. & Maxfield, F. R. Endocytic sorting of lipid analogues differing solely in the chemistry of their hydrophobic tails. J. Cell Biol. 144, 1271-1284 (1999).
88. Moody, D. B. et al. Lipid length controls antigen entry into endosomal and nonendosomal pathways for CD1b presentation. Nature Immunol. 3, 435-442 (2002).
89. Singh, R. D. et al. Caveolar endocytosis and microdomain association of a glycosphingolipid analog is dependent on its sphingosine stereochemistry. J. Biol. Chem. 281, 30660-30668 (2006).
90. Dascher, C. C. & Brenner, M. B. Evolutionary constraints on CD1 structure: insights from comparative genomic analysis. Trends Immunol. 24, 412-418 (2003).
91. Kolter, T. & Sandhoff, K. Principles of lysosomal membrane digestion: stimulation of sphingolipid degradation by sphingolipid activator proteins and anionic lysosomal lipids. Annu. Rev. Cell Dev. Biol. 21, 81-103 (2005).
92. Winau, F. et al. Saposin C is required for lipid presentation by human CD1b. Nature Immunol. 5, 169-174 (2004).
93. Kang, S. J. & Cresswell, P. Saposins facilitate CD1-drestricted presentation of an exogenous lipid antigen to T cells. Nature Immunol. 5, 175-181 (2004).
94. Yuan, W. et al. Saposin B is the dominant saposin that facilitates lipid binding to human CD1d molecules. Proc. Natl Acad. Sci. USA 104, 5551-5556 (2007).
95. Zhou, D. et al. Editing of CD1d-bound lipid antigens by endosomal lipid transfer proteins. Science 303, 523-527 (2003). References 92-95 establish that saposins are required for CD1-dependent antigen presentation and show how they can facilitate lipid binding to CD1 molecules.
96. Hiraiwa, M., Soeda, S., Kishimoto, Y. & O'Brien, J. S. Binding and transport of gangliosides by prosaposin. Proc. Natl Acad. Sci. USA 89, 11254-11258 (1992).
97. Ciaffoni, F. et al. Saposin B binds and transfers phospholipids. J. Lipid Res. 47, 1045-1053 (2006).
98. Schrantz, N. et al. The Niemann-Pick type C2 protein loads isoglobotrihexosylceramide onto CD1d molecules and contributes to the thymic selection of NKT cells. J. Exp. Med. 204, 841-852 (2007).
99. Angenieux, C. et al. The cellular pathway of CD1e in immature and maturing dendritic cells. Traffic 6, 286-302 (2005).
100. Angenieux, C. et al. Characterization of CD1e, a third type of CD1 molecule expressed in dendritic cells. J. Biol. Chem. 275, 37757-37764 (2000).
101. de la Salle, H. et al. Assistance of microbial glycolipid antigen processing by CD1e. Science 310, 1321-1324 (2005).
102. Denzin, L. K. & Cresswell, P. HLA-DM induces CLIP dissociation from MHC class II αβ dimers and facilitates peptide loading. Cell 82, 155-165 (1995).
103. Sloan, V. S. et al. Mediation by HLA-DM of dissociation of peptides from HLA-DR. Nature 375, 802-806 (1995).
104. Manolova, V. et al. Functional CD1a is stabilized by exogenous lipids. Eur. J. Immunol. 36, 1083-1092 (2006).
105. Grant, E. P. et al. Molecular recognition of lipid antigens by T cell receptors. J. Exp. Med. 189, 195-205 (1999).
106. - T lymphocytes to a microbial antigen. Nature 360, 593-597 (1992).
107. + αβ T cell pool. J. Immunol. 162, 366-371 (1999).
108. Kawashima, T. et al. Cutting edge: major CD8 T cell response to live bacillus Calmette-Guérin is mediated by CD1 molecules. J. Immunol. 170, 5345-5348 (2003).
109. + T cells in the CD1-restricted repertoire: derivation of mycobacteria-reactive T cells from leprosy lesions. J. Immunol. 164, 4790-4796 (2000).
110. Gumperz, J. E., Miyake, S., Yamamura, T. & Brenner, M. B. Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining. J. Exp. Med. 195, 625-636 (2002).
111. Lee, P. T., Benlagha, K., Teyton, L. & Bendelac, A. Distinct functional lineages of human Vα24 natural killer T cells. J. Exp. Med. 195, 637-641 (2002).
112. Thomas, S. Y. et al. CD1d-restricted NKT cells express a chemokine receptor profile indicative of Th1-type inflammatory homing cells. J. Immunol. 171, 2571-2580 (2003).
113. + NKT cell subsets with distinct cytokine-producing capacity. Blood 100, 11-16 (2002).
114. Crowe, N. Y. et al. Differential antitumor immunity mediated by NKT cell subsets in vivo. J. Exp. Med. 202, 1279-1288 (2005).
115. +NKT cells: stimulation of IL-12 production by antigen-presenting cells in the innate immune system. J. Immunol. 163, 93-101 (1999).
116. Kitamura, H. et al. The natural killer T (NKT) cell ligand α-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells. J. Exp. Med. 189, 1121-1128 (1999).
117. Vincent, M. S. et al. CD1-dependent dendritic cell instruction. Nature Immunol. 3, 1163-1168 (2002).
118. Brigl, M., Bry, L., Kent, S. C., Gumperz, J. E. & Brenner, M. B. Mechanism of CD1d-restricted natural killer T cell activation during microbial infection. Nature Immunol. 4, 1230-1237 (2003). A new mechanism for activation of iNKT cells, involving the production of cytokines, such as IL-12, and CD1d-restricted self reactivity, was described in this paper.
119. Nieuwenhuis, E. E. et al. CD1d-dependent macrophage-mediated clearance of Pseudomonas aeruginosa from lung. Nature Med. 8, 588-593 (2002).
120. + natural killer T cells by α-galactosylceramide results in development of Th1 response and local host resistance in mice infected with Cryptococcus neoformans. Infect. Immun. 69, 213-220 (2001).
121. Nagarajan, N. A. & Kronenberg, M. Invariant NKT cells amplify the innate immune response to lipopolysaccharide. J. Immunol. 178, 2706-2713 (2007).
122. Galli, G. et al. CD1d-restricted help to B cells by human invariant natural killer T lymphocytes. J. Exp. Med. 197, 1051-1057 (2003).
123. + T cell responses to soluble antigen in vivo through direct interaction with dendritic cells. J. Immunol. 171, 5140-5147 (2003).
124. Moody, D. B. et al. T cell activation by lipopeptide antigens. Science 303, 527-531 (2004).
125. Kawano, T. et al. CD1d-restricted and TCR-mediated activation of Vα14 NKT cells by glycosylceramides. Science 278, 1626-1629 (1997).
126. Vaccaro, A. M. et al. pH-dependent conformational properties of saposins and their interactions with phospholipid membranes. J. Biol. Chem. 270, 30576-30580 (1995).
127. de Alba, E., Weiler, S. & Tjandra, N. Solution structure of human saposin C: pH-dependent interaction with phospholipid vesicles. Biochemistry 42, 14729-14740 (2003).
128. Ahn, V. E., Faull, K. F., Whitelegge, J. P., Fluharty, A. L. & Prive, G. G. Crystal structure of saposin B reveals a dimeric shell for lipid binding. Proc. Natl Acad. Sci. USA 100, 38-43 (2003).
129. Vogel, A., Schwarzmann, G. & Sandhoff, K. Glycosphingolipid specificity of the human sulfatide activator protein. Eur. J. Biochem. 200, 591-597 (1991).
130. Zajonc, D. M. et al. Structure and function of a potent agonist for the semi-invariant natural killer T cell receptor. Nature Immunol. 6, 810-818 (2005).
131. Potterton, E., McNicholas, S., Krissinel, E., Cowtan, K. & Noble, M. The CCP4 molecular-graphics project. Acta Crystallogr. D Biol. Crystallogr. 58, 1955-1957 (2002).
132. Moody, D. B. et al. Structural requirements for glycolipid antigen recognition by CD1b-restricted T cells. Science 278, 283-286 (1997).
133. Fischer, K. et al. Mycobacterial phosphatidylinositol mannoside is a natural antigen for CD1d-restricted T cells. Proc. Natl Acad. Sci. USA 101, 10685-10690 (2004).
134. Matsunaga, I. et al. Mycobacterium tuberculosis pks12 produces a novel polyketide presented by CD1c to T cells. J. Exp. Med. 200, 1559-1569 (2004).